Journal of the New Zealand Medical Association Vol 133 | No 1513 | 24 April 2020 COVID-19—the frontline (a GP perspective) The case for New Zealand to have its own COVID-19 vaccine programme Towards elimination of tuberculosis in New Zealand Changes to management The post-lockdown Variation in volumes and of a non-pandemic illness period should be characteristics of trauma during the COVID-19 used to acquire patients admitted to a level pandemic: case study of effective therapies for one trauma centre during invasive management of future resurgence in national level 4 lockdown for acute coronary syndrome SARS-Cov-2 infections COVID-19 in New Zealand Publication Information published by the New Zealand Medical Association NZMJ Editor NZMA Chair Professor Frank Frizelle Dr Kate Baddock NZMJ Production Editor NZMA Communications Manager Rory Stewart Diana Wolken Other enquiries to: NZMA To contribute to the NZMJ, fi rst read: PO Box 156 www.nzma.org.nz/journal/contribute The Terrace Wellington 6140 © NZMA 2020 Phone: (04) 472 4741 To subscribe to the NZMJ, email
[email protected] Subscription to the New Zealand Medical Journal is free and automatic to NZMA members. Private subscription is available to institutions, to people who are not medical practitioners, and to medical practitioners who live outside New Zealand. Subscription rates are below. All access to the NZMJ is by login and password, but IP access is available to some subscribers. Read our Conditions of access for subscribers for further information www.nzma.org.nz/journal/subscribe/conditions-of-access If you are a member or a subscriber and have not yet received your login and password, or wish to receive email alerts, please email:
[email protected] The NZMA also publishes the NZMJ Digest.